EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough ...Middle East

Medscape - News
Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection fraction, a practice-changing result. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough )

Apple Storegoogle play

Also on site :